PREPARATION AND USE OF CRYSTALLINE FORM TAU OF RIFAXIMIN SOLVATED WITH DEGME
The invention relates to a new crystalline form tau of rifaximin (rifaximin τ), characterized in that it is a solvated form of rifaximin with diethylene glycol monoethyl ether (DEGME).
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; srp |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a new crystalline form tau of rifaximin (rifaximin τ), characterized in that it is a solvated form of rifaximin with diethylene glycol monoethyl ether (DEGME). |
---|